NFG
ALNY icon

Next Financial Group’s Alnylam Pharmaceuticals ALNY Stock Holding History

Next Financial Group’s Portfolio ALNY Stock Details ALNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-150
Closed -$17.9K – 1833
2015
Q1 		$15K Hold
150
– – ﹤0.01% 1095
2014
Q4 		$15K Buy
+150
New +$13.9K 0.01% 1079

Other funds holding ALNY

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $9.69B AUM 55.7% 1-Year Est. Return

Next Financial Group's ALNY Position: Q2 2015 in Review

Next Financial Group sold out of Alnylam Pharmaceuticals (ALNY) in Q2 2015, closing a stake of 150 shares — an estimated $17.9K sold.

Next Financial Group first reported a position in ALNY in Q4 2014 and held it in 2 quarters. The position peaked at $15K in Q1 2015. 278 funds tracked by Wall St. Rank hold ALNY as of Q2 2015.

  • Next Financial Group reported no remaining Alnylam Pharmaceuticals position as of Q2 2015 after selling out during the quarter.
  • Next Financial Group sold 150 Alnylam Pharmaceuticals shares in Q2 2015, an estimated $17.9K.
  • Next Financial Group first reported a position in Alnylam Pharmaceuticals in Q4 2014 and held it in 2 quarters.
  • Next Financial Group's Alnylam Pharmaceuticals position peaked at $15K in Q1 2015.
  • 278 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q2 2015.

Based on Next Financial Group's 13F filing for Q2 2015, filed 29 Jul 2015.